Useful inputs
Product type, process route, target scale, ingredient classes, packaging type, broad operating ranges, and the failure mode or decision under consideration.
FDE / PUBLIC SCOPE NOTE
Start with the operating boundary, not the full formula.
The early FDE batch maps non-confidential product and process signals to possible validation questions. It does not require, request, or publish exact proprietary formula information.
What the first diagnostic read can examine
FDE is a protocol-assisted manual review for early-stage functional beverage, supplement, and nutritional product systems facing a scale-up, stability, or process question.
Diagnostic output
A bounded risk map across thermal, biological, chemical, mechanical, and stability layers, with critical unknowns and proportionate next validation steps.
Keep outside the first read
Exact ratios, complete proprietary formulas, supplier names, customer names, confidential contracts, and any information not needed to frame the operating question.
What FDE does not replace
Laboratory testing, process engineering validation, safety testing, regulatory review, medical or nutrition claim assessment, or a guarantee of scale-up success.
How the boundary protects the work
Limited inputs make the first review easier to scope and reduce unnecessary disclosure. Any anonymized, aggregated learning is retained only when the submitter gives separate consent.